These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5624656)

  • 1. [Clinical use of topical glutathione for cataract].
    Kandori F; Kurimoto S; Fukunaga K; Suyama T; Honda I
    Nippon Ganka Gakkai Zasshi; 1967 Jun; 71(6):689-97. PubMed ID: 5624656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of an eyedrop solution, Tathion, on cataract].
    Fujii S; Takahashi K; Namba K
    Nihon Ganka Kiyo; 1968 Jan; 19(1):136-42. PubMed ID: 5691888
    [No Abstract]   [Full Text] [Related]  

  • 3. [On medicine therapy for cataracts (author's transl)].
    Uchiyama U
    Nippon Ganka Gakkai Zasshi; 1974 Jan; 78(1):41-6. PubMed ID: 4856921
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical glutathione therapy in senile cataracts. Cataract-III.
    Sharma YR; Vajpayee RB; Bhatnagar R; Mohan M; Azad RV; Kumar M; Nath R
    Indian J Ophthalmol; 1989; 37(3):121-6. PubMed ID: 2632447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the aqueous humor dynamics of Pco 2 and pH in the cases of cataract. Effect of the treatment in experimental traumatic cataract of the rabbit].
    Morikawa S
    Nippon Ganka Gakkai Zasshi; 1972 Jul; 76(7):449-57. PubMed ID: 4673695
    [No Abstract]   [Full Text] [Related]  

  • 6. Why are physicians not persuaded by scientific evidence? A grounded theory interview study.
    Sekimoto M; Imanaka Y; Kitano N; Ishizaki T; Takahashi O
    BMC Health Serv Res; 2006 Jul; 6():92. PubMed ID: 16872522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical employment of Tathion injection in ocular disease].
    Fukunaga K; Yamamoto T; Nomura K
    Nippon Ganka Gakkai Zasshi; 1966 Nov; 70(11):1856-67. PubMed ID: 6009663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effect of 2-mercaptopropionyl-glycine (Thiola) for senile cataract].
    Matsuura H; Watanabe T; Kurimoto S
    Nihon Ganka Kiyo; 1969 Dec; 20(12):1173-82. PubMed ID: 4904704
    [No Abstract]   [Full Text] [Related]  

  • 9. [An eye-lotion of aspartate upon senile cataract].
    Oishi M; Fujii S; Takahashi K
    Nihon Ganka Kiyo; 1966 Aug; 17(8):822-7. PubMed ID: 6008804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of cataract].
    Oguchi M; Shimizu Y
    Ganka; 1969 Jan; 11(1):29-37. PubMed ID: 4886885
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of Azapentacene in senile cataract--a double-blind controlled study].
    Fukushi S; Irinoda K; Ishikawa S; Miyata M; Watanabe H; Yonechi K; Sato Y; Suzuki T; Asano T; Mizuno K
    Nippon Ganka Gakkai Zasshi; 1984 Dec; 88(12):1528-47. PubMed ID: 6397985
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of sodium iodide in the treatment of various types of cataracts.
    Singh YP; Saxena R; Chaudhary RM
    J Indian Med Assoc; 1983 Oct; 81(7-8):119-21. PubMed ID: 6676359
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of cataract and medical treatment.
    Eyada KA
    Metab Pediatr Ophthalmol; 1981; 5(2):99-103. PubMed ID: 7289691
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of the inhibitory effect of Quinax on the progression of senile cataract].
    Prost M; Toczołowski J
    Klin Oczna; 1982 Mar; 84(3):71-2. PubMed ID: 6757553
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the effectiveness of Quinax in the prevention of the development of senile cataract].
    Stankiewicz A; Poppe E; Stasiewicz B; Gołebiowska-Hrycukowa A
    Klin Oczna; 1990 Aug; 92(3-4):52-4. PubMed ID: 2263035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 'Caracsol' (sodium-iodide in phospho-mono-calcic vehicle) in cases of incipient senile cataract.
    Consul BN; Mahrotra AS; Mathur GB
    Indian Pract; 1967 Jul; 20(7):527-30. PubMed ID: 6065036
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of taurine therapy in senile cataracts].
    Vodovozov AM; Glotova NM
    Vestn Oftalmol; 1981; (2):44-5. PubMed ID: 7233685
    [No Abstract]   [Full Text] [Related]  

  • 18. Methodology for studies on medical therapy of cataracts: cataract-II.
    Sharma YR; Vajpayee RB; Bhatnagar R; Mohan M; Azad RV; Kumar M; Nath R
    Indian J Ophthalmol; 1989; 37(3):118-20. PubMed ID: 2632446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
    Babizhayev MA
    Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a topical antioxidant formulation including N-acetyl carnosine on canine cataract: a preliminary study.
    Williams DL; Munday P
    Vet Ophthalmol; 2006; 9(5):311-6. PubMed ID: 16939459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.